Cocrystal Pharma (COCP) Short term Debt (2010 - 2013)

Cocrystal Pharma (COCP) has 4 years of Short term Debt data on file, last reported at $206042.0 in Q2 2013.

• For the quarter ending Q2 2013, Short term Debt fell 5.38% year-over-year to $206042.0; the trailing twelve-month figure through Jun 2013 stood at $206042.0 (down 5.38% YoY), and the FY2012 full-year result was $181752.0, down 30.29% from the prior year.
• Short term Debt steadied at $206042.0 in Q2 2013, from $206040.0 in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $284576.0 in Q3 2011 to a low of $181752.0 in Q4 2012.
• A 4-year average of $230649.3 and a median of $227323.5 in 2011 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt slumped 31.74% in 2012 and fell 5.38% in 2013, its largest moves.
• Tracing COCP's Short term Debt over 4 years: stood at $277299.0 in 2010, then retreated by 5.97% to $260741.0 in 2011, then tumbled by 30.29% to $181752.0 in 2012, then climbed by 13.36% to $206042.0 in 2013.
• Business Quant data shows COCP's Short term Debt at $206042.0 in Q2 2013, $206040.0 in Q1 2013, and $181752.0 in Q4 2012.